Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	66172
Country	China

Received	2021-03-22 06:18
Peer-Review Started	2021-03-22 06:22
To Make the First Decision
Return for Revision	2021-06-14 03:48
Revised	2021-06-28 07:08
Second Decision	2021-08-12 03:32
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2021-08-12 08:43
Articles in Press	2021-08-12 08:43
Publication Fee Transferred
Edit the Manuscript by Language Editor	2021-08-31 02:46
Typeset the Manuscript	2021-10-08 16:23
Publish the Manuscript Online	2021-10-13 12:57

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Frontier
Article Title	Engineering nanotheranostic strategies for liver cancer
Manuscript Source	Invited Manuscript
All Author List	Lei Cao, Yu-Qin Zhu, Zhi-Xian Wu, Gao-Xiong Wang and Hong-Wei Cheng
ORCID	Author(s) ORCID Number Lei Cao http://orcid.org/0000-0002-2240-1302 Yu-Qin Zhu http://orcid.org/0000-0002-0494-1866 Zhi-Xian Wu http://orcid.org/0000-0002-0708-6770 Gao-Xiong Wang http://orcid.org/0000-0003-1840-601X Hong-Wei Cheng http://orcid.org/0000-0002-4251-0645
Funding Agency and Grant Number	Funding Agency Grant Number Science and Technology Innovation Joint Fund Project of Fujian Province 2019Y9044 Science and Technology Project of Quanzhou 2018Z155
Corresponding Author	Hong-Wei Cheng, MD, Research Associate, School of Public Health, Xiamen University, Xiangan South Road, Xiangan District, Xiamen 361002, Fujian Province, China. hongwei1026@hotmail.com
Key Words	Liver cancer; Poor prognosis; Nanotheranostic; Drug delivery; Gene delivery; Combination therapy
Core Tip	With the development of nanotheranostic strategies in liver cancer treatment, the efficacy of drug delivery is improved by smart nanoparticles with excellent targeting capacity. To overcome the complex tumor microenvironment, the nanosystems with combined strategies of curative or palliative treatments show the significant synergistic therapeutic effect against unfavorable disadvantages of clinical liver cancer.
Publish Date	2021-10-13 12:57
Citation	Cao L, Zhu YQ, Wu ZX, Wang GX, Cheng HW. Engineering nanotheranostic strategies for liver cancer. World J Gastrointest Oncol 2021; 13(10): 1213-1228
URL	https://www.wjgnet.com/1948-5204/full/v13/i10/1213.htm
DOI	https://dx.doi.org/10.4251/wjgo.v13.i10.1213

Full Article (PDF)	WJGO-13-1213.pdf
Full Article (Word)	WJGO-13-1213.docx
Manuscript File	66172-Review-FilipodiaCL.docx
Answering Reviewers	66172-Answering reviewers.pdf
Audio Core Tip	66172-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	66172-Conflict-of-interest statement.pdf
Copyright License Agreement	66172-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	66172-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	66172-Language certificate.pdf
Supplementary Material	66172-Copyright permission.pdf
Peer-review Report	66172-Peer-review(s).pdf
Scientific Misconduct Check	66172-Scientific misconduct check.pdf
Scientific Editor Work List	66172-Scientific editor work list.pdf
CrossCheck Report	66172-CrossCheck report.pdf